Publications/Abstracts/Presentations Arising from NGVL Support

Publications

The following is a partial list of supported publications. For a complete list, please click here

• Abonour R, Williams DA, Einhorn LH, Hall KM, Chen J, Coffman J, Traycoff CM, Bank A, Kato I, Ward M, Williams SD, Hromas R, Robertson MJ, Smith, FO, Wood, D, Mills B, Srour EF, Cornetta K. Efficient Retrovirus-Mediated Transfer of the Multidrug Resistance 1 Gene into Autologous Human Long-Term Repopulating Hematopoietic Stem Cells. Nature Medicine 6:652-658, 2000


• Bauer TR, Hickstein DD. Gene Therapy for Leukocyte Adhesion Deficiency. Curr Op Mol Therapeutics 2: 383-388, 2000


• Berger C, Blau CA, Huang M-L, Iuliucci JD, Dalgarno DC, Gaschet J, Heimfeld S, Clackson T, Riddell SR. Pharmacologically Regulated Fas-Mediated Death of Adoptively Transferred T Cells in a Nonhuman Primate Model. Blood 103:1261-9, 2004


• Berger C, Flowers MED,Warren EH, Riddell SR. Analysis of Transgene-Specific Immune Responses that Limit the In Vivo Persistence of Adoptively Transferred HSVTK Modified T Cells after Allogeneic Hematopoietic Cell Transplantation. Blood 107:2294-302, 2006


• Bollard CM, Huls MH, Buza E, Weiss H, Torrano V, Gresik MV, Chang J, Gee A, Gottschalk SM, Carrum G, Brenner MK, Rooney CM, Heslop HE. Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma. Clin Lymphoma Myeloma. 6; 342-347, 2006


• Bollard CM. Hodgkin Disease-Are You the Type? Commentary-Genotyping the HLA region in Hodgkin lymphoma: HLA class I is associated with EBV-involved cases and HLA class III is associated with EBV-negative cases. Lancet. 365:2162-3, 2005


• Bollard CM, Huls MH, Lacuesta KC, Brenner MK, Rooney CM, Heslop HE. Generation of autologous LMP2-specific Cytotoxic T cells for patients with relapsed EBV-positive Hodgkin Disease J Immunother. 27: 317-27, 2004


• Bollard CM, Gee AP. Graft Engineering to Enhance Engraftment, Reduce Graft-versus- Host Disease, and Provide a Graft versus-Tumor Effect. In: Hematology, Basic Principles and Practice. Hoffman (ed). Fourth edition. Chapter 101, pages 1801-1828, 2004


• Bollard CM, Kuehnle I, Leen A, Rooney CM, Heslop HE. CTL Therapy for Viral Infections Post Stem Cell Transplant. Biol Blood and Marrow Transplant;10:143- 155, 2004